Cerebrospinal fluid erythropoietin, oxidative stress, and cognitive functions in patients with bipolar disorder and healthy control participants: A longitudinal case-control study

Kamilla W. Miskowiak, Anja H. Simonsen, Morten Meyer, Henrik Enghusen Poulsen, Mira Wilkan, Julie Forman, Steen G. Hasselbalch, Lars V. Kessing, Ulla Knorr

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

38 Downloads (Pure)

Abstract

Persistent cognitive impairments occur in a large proportion of patients with bipolar disorder (BD) but their underlying pathological cellular processes are unclear. The aims of this longitudinal study of BD and healthy control (HC) participants were to investigate (i) the association of brain erythropoietin (EPO) and oxidative stress with cognitive functions and (ii) the changes in brain EPO during and after affective episodes. Participants underwent neurocognitive testing, lumbar punctures for cerebrospinal fluid (CSF) sampling and provided urine spot tests at baseline (all), after an affective episode (patients) and after one year (all). EPO was assayed in the CSF and oxidative stress metabolites related to RNA and DNA damage (8-dihydroguanosine [8-oxo-Guo], 8-hydroxy-2-deoxyguanosine [8-oxo-dG]) were assayed in the CSF and spot urine. Data was available for analyses for 60 BD and 37 HC participants. In unadjusted explorative analyses, higher levels of oxidative stress were associated with poorer verbal memory and psychomotor speed. However, no associations between cognitive functions and CSF levels of EPO or oxidative stress were observed after adjustment for multiple testing. CSF EPO concentrations were unchanged during and after affective episodes. While CSF EPO correlated negatively with CSF DNA damage marker 8-oxo-dG, this association rendered non-significant after adjusting for multiple testing. In conclusion, EPO and oxidative stress do not seem to be robustly related to cognitive status in BD. Further insight into the cellular processes involved in cognitive impairments in BD is necessary to pave the way for novel therapeutic strategies to improve patients’ cognitive outcomes.
OriginalsprogEngelsk
TidsskriftJournal of Psychiatric Research
Vol/bind163
Sider (fra-til)240-246
ISSN0022-3956
DOI
StatusUdgivet - jul. 2023

Fingeraftryk

Dyk ned i forskningsemnerne om 'Cerebrospinal fluid erythropoietin, oxidative stress, and cognitive functions in patients with bipolar disorder and healthy control participants: A longitudinal case-control study'. Sammen danner de et unikt fingeraftryk.

Citationsformater